fda warning letters to compounding pharmacies bpc 157 Next week, July 23-24, the FDA's Pharmacy Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List. Why does this matter? If these peptides are ultimately FDA's Overreach on Compounded Peptides
Description
Radbill B, Murphy B, LeRoith D

In recent years, quantitative susceptibility mapping (QSM) based on 3D multiecho flow compensated sequences have possibly had a better effect on the direct measurement of susceptibility 24,32

& Ells, C
cGAS is activated by DNA in a length-dependent manner

PMID 26291291